These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6415230)

  • 1. Immunological properties of monoclonal antibodies specific for meningococcal polysaccharides: the protective capacity of IgM antibodies specific for polysaccharide group B.
    Moreno C; Hewitt J; Hastings K; Brown D
    J Gen Microbiol; 1983 Aug; 129(8):2451-6. PubMed ID: 6415230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human monoclonal antibody with protective activity for Escherichia coli K1 and Neisseria meningitidis group B infections.
    Raff HV; Devereux D; Shuford W; Abbott-Brown D; Maloney G
    J Infect Dis; 1988 Jan; 157(1):118-26. PubMed ID: 3121759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo.
    Kim KS; Kang JH; Cross AS; Kaufman B; Zollinger W; Sadoff J
    J Infect Dis; 1988 Jan; 157(1):47-53. PubMed ID: 2447199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
    Park IH; Lin J; Choi JE; Shin JS
    Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity of two IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide.
    Hurpin CM; Carosella ED; Cazenave PA
    Hybridoma; 1992 Dec; 11(6):677-87. PubMed ID: 1284118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis.
    Pon RA; Lussier M; Yang QL; Jennings HJ
    J Exp Med; 1997 Jun; 185(11):1929-38. PubMed ID: 9166422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of the immune response to the group B polysaccharide of Neisseria meningitidis.
    Lifely MR; Esdaile J
    Immunology; 1991 Nov; 74(3):490-6. PubMed ID: 1722773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of immunotherapeutic approaches for the potential treatment of infections caused by K1-positive Escherichia coli.
    Cross AS; Zollinger W; Mandrell R; Gemski P; Sadoff J
    J Infect Dis; 1983 Jan; 147(1):68-76. PubMed ID: 6401788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive transfer of meningococcal group B polysaccharide antibodies to the offspring of pregnant rabbits and their protective role against infection with Escherichia coli K1.
    Lifely MR; Esdaile J; Moreno C
    Vaccine; 1989 Feb; 7(1):17-21. PubMed ID: 2497598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.
    Zollinger WD; Mandrell RE
    Infect Immun; 1983 Apr; 40(1):257-64. PubMed ID: 6403466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine monoclonal antibodies for detection of antigens and culture identification of Neisseria meningitidis group B and Escherichia coli K-1.
    Krambovitis E; McIllmurray MB; Lock PA; Holzel H; Lifely MR; Moreno C
    J Clin Microbiol; 1987 Sep; 25(9):1641-4. PubMed ID: 3116036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The form variation of the capsular polysaccharide K1 is not a critical virulence factor of Escherichia coli in a neonatal mouse model of infection.
    Colino J; Outschoorn I
    Microb Pathog; 1999 Oct; 27(4):187-96. PubMed ID: 10502459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 14. Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children.
    Lepow ML; Beeler J; Randolph M; Samuelson JS; Hankins WA
    J Infect Dis; 1986 Dec; 154(6):1033-6. PubMed ID: 3097160
    [No Abstract]   [Full Text] [Related]  

  • 15. Human immunoglobulin M paraproteins cross-reactive with Neisseria meningitidis group B polysaccharide and fetal brain.
    Azmi FH; Lucas AH; Spiegelberg HL; Granoff DM
    Infect Immun; 1995 May; 63(5):1906-13. PubMed ID: 7729901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1.
    Azmi FH; Lucas AH; Raff HV; Granoff DM
    Infect Immun; 1994 May; 62(5):1776-86. PubMed ID: 8168940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymic-dependence and immune memory in mice vaccinated with meningococcal polysaccharide group B complexed to outer membrane protein.
    Moreno C; Esdaile J; Lifely MR
    Immunology; 1986 Mar; 57(3):425-30. PubMed ID: 3082745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid.
    Granoff DM; Bartoloni A; Ricci S; Gallo E; Rosa D; Ravenscroft N; Guarnieri V; Seid RC; Shan A; Usinger WR; Tan S; McHugh YE; Moe GR
    J Immunol; 1998 May; 160(10):5028-36. PubMed ID: 9590252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. II. Specificity.
    Rubinstein LJ; Stein KE
    J Immunol; 1988 Dec; 141(12):4357-62. PubMed ID: 3143763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.
    Jennings HJ; Roy R; Gamian A
    J Immunol; 1986 Sep; 137(5):1708-13. PubMed ID: 3091688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.